Public Sector Pension Investment Board Increases Position in Privia Health Group, Inc. $PRVA

Public Sector Pension Investment Board grew its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 25.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 450,010 shares of the company’s stock after buying an additional 92,507 shares during the quarter. Public Sector Pension Investment Board owned 0.37% of Privia Health Group worth $11,205,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Van Berkom & Associates Inc. increased its stake in Privia Health Group by 30.1% in the third quarter. Van Berkom & Associates Inc. now owns 3,774,565 shares of the company’s stock worth $93,987,000 after purchasing an additional 873,344 shares during the period. Qube Research & Technologies Ltd grew its holdings in shares of Privia Health Group by 93.3% in the second quarter. Qube Research & Technologies Ltd now owns 609,278 shares of the company’s stock worth $14,013,000 after purchasing an additional 294,101 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new position in Privia Health Group in the 2nd quarter worth about $6,219,000. First Trust Advisors LP lifted its holdings in Privia Health Group by 482.7% during the 2nd quarter. First Trust Advisors LP now owns 279,005 shares of the company’s stock valued at $6,417,000 after buying an additional 231,125 shares in the last quarter. Finally, Great Lakes Advisors LLC purchased a new stake in Privia Health Group in the 3rd quarter valued at about $4,487,000. 94.48% of the stock is owned by institutional investors.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $22.39 on Monday. The company has a market capitalization of $2.75 billion, a PE ratio of 172.24, a P/E/G ratio of 1.57 and a beta of 0.83. The company has a 50-day simple moving average of $23.39 and a two-hundred day simple moving average of $23.32. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51.

Insider Activity at Privia Health Group

In other news, CFO David Mountcastle sold 23,887 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $25.03, for a total transaction of $597,891.61. Following the completion of the sale, the chief financial officer owned 172,909 shares in the company, valued at approximately $4,327,912.27. This represents a 12.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Matthew Shawn Morris sold 13,647 shares of the business’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $25.01, for a total value of $341,311.47. Following the transaction, the director owned 68,188 shares in the company, valued at approximately $1,705,381.88. This trade represents a 16.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 10.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

PRVA has been the topic of a number of research reports. Wolfe Research set a $31.00 target price on shares of Privia Health Group in a research report on Tuesday, January 6th. Stephens reissued an “overweight” rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, December 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research report on Monday, December 29th. JPMorgan Chase & Co. upped their target price on Privia Health Group from $32.00 to $33.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Finally, Canaccord Genuity Group raised their price target on Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, November 12th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Privia Health Group presently has an average rating of “Moderate Buy” and an average target price of $30.50.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.